Han S, Munawar U, Truger M, Gerhard-Hartmann E, Verbruggen C, Pfeiffer L, Hainold A-S, Kurian S, Nerreter S, Besant E, Vogt C, Rein N, Köppel M, Lehmann J, Schmitt F, Tamamushi Y, Zhou X, Steinbrunn T, Haferlach C, Rosenwald A, Einsele H, Rasche L, Waldschmidt JM, Kortüm MK. Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myeloma. Haematologica; https://doi.org/10.3324/haematol.2025.289162 [Early view].